OCUL peer analysis
Ocular Therapeutix (OCUL) against its competitors: price, today's move, 1-year return and market value side by side.
OCUL and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BLCO Bausch + Lomb | $20.01 | 0.05% | 33.94% | – |
| EYPT EyePoint | $0.37 | 7.58% | -97.14% | $30.04M |
| GKOS Glaukos | $238.61 | 0.43% | 170.93% | $14.07B |
| HROW Harrow | $28.15 | -0.18% | -25.47% | $1.06B |
| KOD Kodiak Sciences | $97.62 | -1.57% | 438.62% | $6.23B |
| OCGN Ocugen | $0.76 | 4.73% | -51.35% | $238.29M |
| OCS Oculis | $7.71 | -6.66% | -60.01% | – |
| OTLK Outlook Therapeutics | $0.47 | 0.23% | -62.76% | $113.96M |
| SGP SpyGlass Pharma | $33.64 | 4.34% | – | – |
| STAA Staar Surgical | $24.94 | 1.63% | -3.59% | $1.23B |
| OCUL Ocular Therapeutix | $6.71 | -0.30% | -42.45% | $1.53B |
- OCUL's peers: BLCO (Bausch + Lomb), EYPT (EyePoint), GKOS (Glaukos), HROW (Harrow), KOD (Kodiak Sciences), OCGN (Ocugen), OCS (Oculis), OTLK (Outlook Therapeutics).
Updated 2026-11-03 12:35 UTC